期刊文献+

MMP-9及TIMP-1在甲状腺癌组织及外周血中的表达及临床意义 被引量:3

Expression of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 in Thyroid Carcinoma Tissue and Their Concentrations in Serum
下载PDF
导出
摘要 目的探讨甲状腺癌组织中基质金属蛋白酶-9(MMP-9)和组织金属蛋白酶抑制剂-1(TIMP-1)的表达,以及血清中MMP-9和TIMP-1浓度与肿瘤浸润、转移的关系。方法采用免疫组织化学SP法测定32例甲状腺癌组织、23例癌旁组织及30例良性甲状腺病变组织标本中MMP-9和TIMP-1的表达,并应用酶联免疫吸附试验(ELISA)方法检测MMP-9和TIMP-1在其中21例甲状腺癌和19例良性甲状腺病变患者外周血清中的浓度。结果MMP-9及TIMP-1在甲状腺癌组织中呈高表达(75.0%、56.3%),在癌旁组织及良性病变组织中呈低表达(30.4%、21.7%,26.7%、23.3%),P<0.05。MMP-9和TIMP-1蛋白的表达与肿瘤浸润程度、淋巴结转移和TNM分期有关(P<0.05),MMP-9蛋白表达与TIMP-1蛋白表达呈负相关(r=-0.509,P=0.003)。甲状腺癌组MMP-9和TIMP-1的血清浓度明显高于甲状腺良性疾病组(P=0.000,P=0.037)。甲状腺癌组织中MMP-9和TIMP-1蛋白表达高者相应血清中的MMP-9和TIMP-1浓度也较高(P<0.05)。结论检测甲状腺肿瘤患者病变组织中MMP-9和TIMP-1的表达情况及外周血中MMP-9和TIMP-1浓度有助于甲状腺良、恶性病变的鉴别诊断,并可作为甲状腺癌预后评估的依据之一。 Objective To explore the protein expressions of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1), and to investigate their relationships between their serum concentration before operation and the infiltration and metastasis of thyroid carcinoma. Methods The protein expressions of MMP-9 and TIMP-1 in 32 cases of thyroid carcinomas, 23 cases of adjacent tissues and 30 cases of benign hyperplastic lesions were measured by using immunohistochemistry. The preoperative serum concentrations of MMP-9 and TIMP-1 in 21 cases of thyroid carcinomas and 19 cases of benign hyperplastic lesions were determined by enzyme-linked immunosorbent assay. Results The positive expression rates of MMP-9 and TIMP-1 in tumor tissues were significantly higher (75.0% , 56.3% )than those in adjacent tissues and benign hyperplastic lesions (30.4% , 21.7% ; 26.7%, 23.3%) P〈0.05. There were correlations between the expressions of MMP-9 and TIMP-1 and the local infiltrative degrees, lymph node metastasis and TNM stage (P〈0.05). There was a negative correlation between the expression of MMP-9 and the expression of TIMP-1 (r=-0. 509, P=0. 003). The concentration of MMP-9 in serum of thyroid carcinoma patients was ( 122.60±36.20) ng/ml, whereas TIMP- 1 was (59.44±38.65) ng/ml, both of which were significantly higher compared to those of benign group (P〈0.05). In addition, there was a positive correlation between the expressions of MMP-9/TIMP 1 in the carcinoma tissues and their concentrations in serum (P〈0.05). Conclusion To detection the expressions of MMP-9 and TIMP-1 in the lesion and their concentrations in the serum may not only contribute to the differential diagnosis of thyroid tumors, but may also help to predict the prognosis of the carcinoma.
出处 《中国普外基础与临床杂志》 CAS 2007年第4期437-441,共5页 Chinese Journal of Bases and Clinics In General Surgery
基金 广西壮族自治区自然科学基金资助项目(项目编号:桂科自0447065)
关键词 甲状腺癌 基质金属蛋白酶-9 组织金属蛋白酶抑制剂-1 Thyroid carcinoma Matrix metalloproteinase-9 Tissue inhibitor of metalloproteinase-1
  • 相关文献

参考文献4

二级参考文献18

  • 1Li Hou Ying Li Yong-Hua Jia Bo Wang Yi Xin Mao-Ying Ling Shen Lü Department of Pathology,Dalian Medical University,Dalian 116027,Liaoning Province,ChinaDepartment of Biochemistry,Dalian Medical University,Dalian 116027,Liaoning Province,China.Molecular mechanism about lymphogenous metastasis of hepatocarcinoma cells in mice[J].World Journal of Gastroenterology,2001,7(4):532-536. 被引量:47
  • 2MINGShu-hong,SUNTie-ying,XIAOWei,XUXiao-mao.Matrix metalloproteinases-2,-9 and tissue inhibitor of metallo-proteinase-1 in lung cancer invasion and metastasis[J].Chinese Medical Journal,2005(1):69-72. 被引量:14
  • 3曹世龙.乳腺癌的预后指标[A]..肿瘤学新理论与新技术[C].上海:上海科技教育出版社,1997.721-741.
  • 4Heppner KJ, Matrisisan LM, Jensen BA, et al. Expression of most matrix metalloprteinase family member in breast cancers represents a tumor-induced host response[J]. Am J Pathol,1996, 149( 1 ): 273 - 282.
  • 5Luparello C, Avanzato G, Carella C, et al. Tissue inhibitor of metalloproteinase (TIMP)-1 and proliferative behaviour of clonal breast cancer cells[J]. Breast Cancer Res Treat, 1999,54(3):235 - 244.
  • 6Yoshikawa T, Saitoh M, Tsuburaya A, et aL Tissue inhibitor of matrix metalloproteinase-1 in the plasma of patients with gastric careinoma: a possible marker for serosal invasion and metastasis[J]. Caneer, 1999,86 (10):1929-1935.
  • 7Talvensaari-Mattila A, Paakko P, Hoyhtya M, et al. Matrix metalloproteinase-2 immunoreactive protein: A marker of aggressiveness in breast carcinoma[J]. Cancer, 1998, 83(6):1153 - 1162.
  • 8Schott RJ, Morrow LA. Growth factors and angiogenesis [J].Cardiovasc Res, 1993; 27(7): 1155
  • 9Nabors LB, Suswam E, Huang Y, et al. Tumor necrosis factor alpha induces angiogenic factor up-regulation in malignant glioma cells: a role for RNA stabilization and HuR [J]. Cancer Res,2003; 63(14): 4181
  • 10Huang S, Ullrich SE, Bar-Eli M. Regulation of tumor growth and metastasis by interleukin-10: the melanoma experience [J].J Interferon Cytokine Res, 1999; 19(7): 697

共引文献113

同被引文献59

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部